Stanford University
Showing 12,721-12,740 of 36,203 Results
-
Kelsey Hirotsu, MD
Clinical Assistant Professor, Dermatology
BioDr. Kelsey Hirotsu is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. She completed her fellowship in Mohs Micrographic Surgery & Dermatologic Oncology at the University of California San Diego. During fellowship she received additional training in cosmetic dermatology and laser procedures. She completed her dermatology residency at Stanford after graduating from Stanford University School of Medicine with a scholarly concentration in bioengineering. Dr. Hirotsu earned her Bachelor of Science degree in Chemical & Biomolecular Engineering at Johns Hopkins University.
Dr. Hirotsu has presented at national and international dermatology conferences. She is a regularly invited reviewer for peer-reviewed journals and has authored numerous publications in top dermatology journals. -
Julia Hirsch
Ph.D. Student in Religious Studies, admitted Autumn 2021
Master of Arts Student in Religious Studies, admitted Autumn 2025BioJulia Hirsch is a Ph.D. student in the Religious Studies Department at Stanford University, where she focuses on Indo-Tibetan Buddhism. She holds a B.A. from Boston College in Philosophy with minors in Psychoanalytics and Women’s & Gender Studies (2015). She received her M.A. in the History of Art and Archaeology: Religious Arts of Asia from SOAS University of London (2020).
Julia’s current research explores Buddhist material religion and visual culture, power objects, and ritual from an art-historical perspective. Of particular interest are relic cults, funerary rites, and the importance—and soteriological potential—of sensory encounter in South Asian and Himalayan traditions.
Prior to joining Stanford, Julia worked for several years at Tricycle: The Buddhist Review, where she continues to serve as a contributing editor covering Buddhist art, film, and publishing. -
Karen G. Hirsch, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
Current Research and Scholarly InterestsDr. Karen G. Hirsch cares for critically ill patients with neurologic disorders in the intensive care unit. Dr. Hirsch's research focuses on using continuous and discrete multi-modal data to develop phenotypes and identify signatures of treatment responsiveness in patients with coma after cardiac arrest. She is the Co-PI of PRECICECAP (PRecision Care In Cardiac ArrEst - ICECAP, NINDS R01 NS119825-01). The research team works closely with collaborators in data science at Stanford and with industry partners to apply machine learning analyses to complex multi-modal ICU data. Dr. Hirsch also studies neuro-imaging in post-cardiac arrest coma and traumatic brain injury, and with colleagues in Cardiac Anesthesia and Cardiothoracic Surgery, Dr. Hirsch studies neurologic outcomes in patients on mechanical circulatory support including ECMO.
Along with colleagues in Biomedical Ethics, Dr. Hirsch studies brain death, organ donation, and neuroethics. She is the Co-PI of BCI-DEF (Brain Computer Interfaces and Disability: Developing an Inclusive Ethical Framework, NIMH 1R01MH130518-01) which is a BRAIN Initiative funded study that is qualitatively evaluating end user perspectives about the benefits, risks, and ethical challenges of Brain Computer Interfaces for patients with acute stroke or traumatic brain injury.
Dr. Hirsch is broadly interested in improving neurologic outcomes after acute severe brain injury, identifying early phenotypes to guide precision medicine in neurocritical care, and exploring ethical issues in neurocritical care and novel neurotechnology. Dr. Hirsch greatly appreciates the importance of team science and collaboration. -
Mark Hlatky, MD
Professor of Health Policy, of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsMy main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.
